Sector
PharmaceuticalsOpen
₹40.59Prev. Close
₹39.79Turnover(Lac.)
₹1.38Day's High
₹40.59Day's Low
₹37.3652 Week's High
₹47.7752 Week's Low
₹24.18Book Value
₹-1.62Face Value
₹10Mkt Cap (₹ Cr.)
14.78P/E
0EPS
0Divi. Yield
016 Aug 2023
12:00 AM
BookCloser
20 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
16 Aug 2023
12:00 AM
AGM
Announcement Date: 16 Aug, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 4.45 | 4.45 | 4.45 | 4.45 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.4 | 1.51 | 1.37 | 0.61 |
Net Worth | 5.85 | 5.96 | 5.82 | 5.06 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 20.91 | 11.9 | 0 | 0 |
yoy growth (%) | 75.77 | 0 | 0 | |
Raw materials | -11.26 | -5.78 | 0 | 0 |
As % of sales | 53.85 | 48.57 | 0 | 0 |
Employee costs | -2.91 | -2.13 | -0.01 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | 0.73 | 0 | 0 | 0.01 |
Depreciation | -1 | -1.09 | 0 | 0 |
Tax paid | -0.3 | 0 | -0.01 | -0.01 |
Working capital | -0.24 | -2.57 | 0.01 | |
Other operating items |
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 75.77 | 0 | 0 | |
Op profit growth | 63.49 | -2,069.75 | 12.91 | |
EBIT growth | 2,335.31 | 587.94 | -55.19 | |
Net profit growth | 78,904.6 | -106.88 | 108.03 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Umang Alkesh Gosalia
Non-Exec. & Independent Dir.
Ami R Shah
Company Sec. & Compli. Officer
Yash Vora
Independent Director
Nikhil S. Uchat
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Parmax Pharma Ltd
Summary
Incorporated in Nov.94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmaxs pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May97.
Read More
What is the Parmax Pharma Ltd share price today?
The Parmax Pharma Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹39.5 today.
What is the Market Cap of Parmax Pharma Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Parmax Pharma Ltd is ₹14.78 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Parmax Pharma Ltd?
The PE and PB ratios of Parmax Pharma Ltd is 0 and -24.46 as of 22 Jul ‘24
What is the 52 Week High and Low of Parmax Pharma Ltd?
The 52-week high/low is the highest and lowest price at which a Parmax Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Parmax Pharma Ltd is ₹24.18 and ₹47.77 as of 22 Jul ‘24
What is the CAGR of Parmax Pharma Ltd?
Parmax Pharma Ltd's CAGR for 5 Years at 17.00%, 3 Years at -14.18%, 1 Year at 34.93%, 6 Month at 21.87%, 3 Month at 33.43% and 1 Month at 36.13%.
What is the shareholding pattern of Parmax Pharma Ltd?
The shareholding pattern of Parmax Pharma Ltd is as follows:
Promoters - 30.80 %
Institutions - 0.00 %
Public - 69.20 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
